1  2  3  
  • Basic Info
Licensed from
Generic: arabinoxylan
treats Cancer and Diabetes

To get info about second drug, type a name above.


Adults (18 years and older)

In general, 600 milligrams a day in a divided dose has been used for daily health maintenance. The following doses have been used in scientific study, but are not proven effective or safe. For cancer, 3 grams of MGN- 3 has been taken daily for up to six months in patients with different types of malignancies (such as multiple myeloma, leukemia, and cancers of the prostate, breast, cervix). Doses of 15, 30, and 45 milligrams per kilogram of MGN- 3 have also been taken daily for two months.

For diabetes, 1- 12 grams of arabinoxylan- rich fiber has been used daily.

Children (younger than 18 years)

There is currently a lack of available scientific evidence to recommend the use of arabinoxylan in children.


DISCLAIMER: Many complementary techniques are practiced by healthcare professionals with formal training, in accordance with the standards of national organizations. However, this is not universally the case, and adverse effects are possible. Due to limited research, in some cases only limited safety information is available.


Avoid in individuals with a known allergy or hypersensitivity to arabinoxylan, mushrooms, yeast or rice bran.

Users of MGN- 3 (BioBran®) should be aware of other constituents (cornstarch, dextrin, tricalcium phosphate, silicon dioxide). Patients with allergies to other constituents should not take MGN- 3.

Side Effects and Warnings

In general, safety data are lacking; however, arabinoxylan has been well tolerated in clinical practice in Japan at recommended doses for short periods of time.

Arabinoxylan products like MGN- 3 (BioBran®) may contain high calcium and phosphorus levels, which may be harmful for patients with compromised renal (kidney) function.

Patients with diabetes and those taking blood sugar lowering medications should use arabinoylan cautiously because arabinoxylan may lower blood sugar.

Pregnancy and Breastfeeding

Arabinoxylan is not recommended in pregnant or breastfeeding women due to a lack of available scientific evidence.

 1  2  3